Are there any clinical trials for Follicular Lymphoma I should consider

According to the NCCN Guidelines for Follicular Lymphoma, clinical trials are an important treatment option that should be considered at various points in your care journey. Let me break down the key information about clinical trials:

According to the NCCN Guidelines:

• Clinical trials help bring new therapies to patients and advance treatment for everyone
• You should consider asking your care team about access to clinical trials at any point during your treatment journey
• Clinical trials may be especially relevant if you've had multiple lines of therapy

The NCCN Guidelines specifically mention several newer treatment approaches being studied in clinical trials, including:

• Bispecific antibody therapies (like Epcoritamab-bysp and Mosunetuzumab-axgb)
• CAR T-cell therapies (including Yescarta, Breyanzi, and Kymriah)
• New targeted therapy combinations

Important considerations when discussing clinical trials with your doctor:

1. Ask about trials during your initial treatment planning
2. Discuss trials again if your lymphoma returns or doesn't respond to standard treatments
3. Consider trials that are testing new combinations of approved therapies

To find specific trials, I recommend:

1. Discussing options with your oncology team
2. Visiting the National Cancer Institute's clinical trial finder
3. Consulting with the Lymphoma Research Foundation's Clinical Trial Information Service

Remember: The decision to participate in a clinical trial is personal and should be made in consultation with your healthcare team. Your doctor can help determine which trials might be most appropriate for your specific situation.

Sources:

• NCCN Guidelines for Patients: Follicular Lymphoma (2024), Section 24, Pages 26
• NCCN Guidelines for Patients: Follicular Lymphoma (2024), Section 48, Pages 50 (regarding specific newer therapies being studied)

Would you like me to provide more specific information about any of these aspects of clinical trials?